ARS Pharmaceuticals
SPRY
SPRY
68 hedge funds and large institutions have $1.21B invested in ARS Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 23 closing their positions.
Holders
68
Holders Change
+6
Holders Change %
+9.68%
% of All Funds
1.2%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
29
Increased
12
Reduced
12
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$209M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$47.4M |
| 3 |
3
BlackRock
New York
|
$53.2M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$12.5M |
| 5 |
5
D.E. Shaw & Co
New York
|
$8.96M |
